Global Microbiology Testing Market, By Test Type (Bacterial, Viral, Fungal), Product (Instruments, Reagents), Indication (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infection, Periodontal Diseases, Others), Application (Pharmaceutical Applications, Food Testing Applications, Clinical Applications, Energy Applications, Chemical and Material Manufacturing Applications, Environmental Applications), End User (Hospitals and Diagnostic Centers, Custom Lab Service Providers, Academic, and Research Institutes) – Industry Trends and Forecast to 2030.
Microbiology Testing Market Analysis and Size
An increasing number of aerobic and anaerobic tests are creating the way for the growth of microbiology testing. As per WHO, around 7 million people get infected by influenza in the U.S. every year. This creates a huge scope of growth for research and development proficiencies associated with microbiology testing. Several new government policies in enhancing the diagnostic and testing processes will ultimately lead to the growth of microbiology testing as it is an important component in testing viruses.
Data Bridge Market Research analyses that the microbiology testing market, which was USD 4.61 billion in 2022, would rise to USD 9.26 billion by 2030 and is expected to undergo a CAGR of 9.1% during the forecast period from 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Microbiology Testing Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Test Type (Bacterial, Viral, Fungal), Product (Instruments, Reagents), Indication (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infection, Periodontal Diseases, Others), Application (Pharmaceutical Applications, Food Testing Applications, Clinical Applications, Energy Applications, Chemical and Material Manufacturing Applications, Environmental Applications), End User (Hospitals and Diagnostic Centers, Custom Lab Service Providers, Academic, and Research Institutes)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Cerner Corporation (U.S.), Medtronic (Ireland), Masimo (U.S.), Koninklijke Philips N.V. (Netherlands), General Electric (U.S.), Stryker (U.S.), iHealth Labs Inc., (U.S.), Cisco (U.S.), Silicon & Software Systems Ltd. (Ireland), Spectrum Medical (U.K.), Hill-Rom Services Inc. (U.S.), Iatric Systems Inc. (U.S.), Silex Technology America, Inc. (Japan), Digi International Inc. (U.S.), Baxter (U.S.), TE Connectivity (Switzerland), and Medicollector (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Microbiology testing is an analytical technique used to determine the microorganisms in numerous samples such as biological, food and beverage, and environmental samples. Microbiology testing uses numerous chemical, biological, molecular, and biochemical methods. It is majorly applied to disease-causing and spoilage microorganisms. Among all other tests, three are the most common: polymerase chain reaction testing, immunoassays, and culture media.
Global Microbiology Testing Market Dynamics
Drivers
- Growing Cases of STD
The huge increase in the STD rate demands rapid use of microbiology testing. According to the data published by the WHO, more than 1 million sexually transmitted infections are acquired worldwide each day; most of them will be asymptomatic in 2022. It also stated that there are around 374 million new infections yearly, with 1 out of 4 sexually transmitted infections such as chlamydia, trichomoniasis, gonorrhea, and syphilis. These diseases need immediate testing to identify the responsible virus for faster treatment processes. Thus, this factor boosts market growth.
- Increasing Strategic Product Launches Associated with Microbiology Testing
The growing incidence of infectious diseases and several strategies adopted by major market players, such as product launches and expansions of services, are anticipated to drive the growth of the microbiology testing market. For instance, STEMart launched microbiology and sterility testing for sterile and non-pyrogenic medical devices in 2022. Therefore, growing service launches by major market players are anticipated to improve market growth during the forecast period. Thus, this factor boosts market growth.
Opportunities
- Increasing Funding by Organizations
Increasing government and private funds for research and development boost the market's growth. For instance, the Department of Science and Technology (DST), India, announced funding of around USD 26.42 million to several scientific institutions, startups, and industries to develop new advanced innovative solutions to fight the COVID-19 pandemic in 2020. These solutions involve rapid and accurate diagnosis kits, protection equipment, and other necessary solutions. Thus, this factor boosts market growth.
- Growing Number of Collaborations between Market Players
Several market players collaborate with small companies to invest in their new innovative technologies and develop new infectious disease tests. For instance, CSL Behring, a U.S. biotherapeutics company, and South Dakota-based SAB Therapeutics collaborated with each other for clinical trials of its antibody-based treatment SAB-185 on COVID-19 patients. Thus, this type of collaboration enhances market growth.
Restraints/Challenges
- Limited Reimbursement in Developing Regions
In many countries, late reimbursement is a major barrier to market growth. Reimbursement for microbiology testing is a complex process. The reimbursement process's complexity is a major hindrance for this market. Furthermore, several countries' lack of standardized reimbursement policies impedes the market growth. Therefore, the lack of reimbursement in emerging nations hampers the market growth.
- Lack of Accuracy of Tests
It has been witnessed many times that testing kits and devices can show false-negative results. The microbial testing kits often lack accuracy due to improper sample loading and unloading. This lack of accuracy in microbiology testing is estimated to restrain the market's growth.
This microbiology testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the microbiology testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2022, IDEXX acquired Tecta-PDS, an innovative Canadian company that has launched automation to water microbiology testing for parameters including E. coli and total coliforms. The acquisition assisted IDEXX in increasing its range of water microbiology testing options for both laboratory-based and in-field testing.
- In 2022, Archer Daniels Midland (ADM) launched a new microbiology laboratory at its ADM Specialty Manufacturing facility in Decatur, Illinois. The project expanded the site's microbiology laboratory footprint on a huge scale and increased the location's testing capabilities.
Global Microbiology Testing Market Scope
The microbiology testing market is segmented on the basis of test type, product, indication, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Bacterial
- Viral
- Fungal
Products
- Instruments
- Laboratory Instruments
- Incubators
- Gram Strainers
- Bacterial Colony Counters
- Autoclave Sterilizers
- Microbial Air Samplers
- Anaerobic Culture Systems
- Petri Dish Fillers
- Blood Culture Systems
- Microbial Culture Systems
- Others
- Microbiology Analyzers
- Molecular Diagnostic Instruments
- Microscopes
- Mass Spectrometers
- Reagents
- Pathogen-Specific Kits
- General Reagents
Indication
- Respiratory Diseases
- Bloodstream Infections
- Gastrointestinal Diseases
- Sexually Transmitted Diseases
- Urinary Tract Infection
- Periodontal Diseases
- Others
Application
- Pharmaceutical
- Food Testing
- Clinical
- Energy
- Chemical and Material Manufacturing
- Environmental
End User
- Hospitals and Diagnostic Centers
- Custom Lab Service Providers
- Academic and Research Institutes
Microbiology Testing Market Regional Analysis/Insights
The microbiology testing market is analyzed and market size insights and trends are provided by test type, product, indication, application and end user as referenced above.
The countries covered in the microbiology testing market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the microbiology testing market because of the huge base of healthcare facilities, increasing investment from major market players in the growth of advanced devices. Also, well-established distribution channels for clinical microbiology product manufacturers, and a growing number of research activities further boost the market growth.
Asia-Pacific is expected to witness significant growth due to the rise in government initiatives to raise awareness and favorable regulatory policies to increase the adoption rate for microbiology testing. Also, other advanced diagnostic methods, and the higher demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The microbiology testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for microbiology testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the microbiology testing market. The data is available for historic period 2011-2021.
Competitive Landscape and Microbiology Testing Market Share Analysis
The microbiology testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to microbiology testing market.
Some of the major players operating in the microbiology testing market are:
- Cerner Corporation (U.S.)
- Medtronic (Ireland)
- Masimo (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- General Electric (U.S.)
- Stryker (U.S.)
- iHealth Labs Inc., (U.S.)
- Cisco (U.S.)
- Silicon & Software Systems Ltd. (Ireland)
- Spectrum Medical (U.K.)
- Hill-Rom Services Inc. (U.S.)
- Iatric Systems Inc. (U.S.)
- Silex Technology America, Inc. (Japan)
- Digi International Inc. (U.S.)
- Baxter (U.S.)
- TE Connectivity (Switzerland)
- Medicollector (U.S.)
SKU-